Hosted on MSN12h
HC Wainwright & Co. Initiates Coverage of CRISPR Therapeutics (CRSP) with Buy Recommendation
Fintel reports that on February 3, 2025, HC Wainwright & Co. initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...
H.C. Wainwright Raises BlackSky Technology Inc. (BKSY) Price Target to $20, Maintains ‘Buy’ Amid Strong Contract Growth
We recently compiled a list of the 10 Trending AI Stocks That Analysts Are Monitoring. In this article, we are going to take ...
bovnews15h
The BBAI Conundrum: Why BigBear.ai Holdings Inc’s Stock Is Making Headlines Again
H.C. Wainwright has recently reiterated BigBear.ai Holdings Inc (BBAI) stock to Buy rating, as announced on December 30, 2024, according to Finviz. Earlier, on January 9, 2024, Cantor Fitzgerald had ...
Knightscope, Inc. (KSCP) Receives ‘Buy’ Rating from H.C. Wainwright with $16 Target
We recently compiled a list of the 10 Trending AI Stocks on Wall Street’s Radar. In this article, we are going to take a look ...
H.C. Wainwright maintains $80 target on Beam Therapeutics stock
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $80.00 price target on Beam Therapeutics Inc ...
Crispr Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Mitchell Kapoor initiated coverage of Crispr Therapeutics (CRSP) with a Buy rating and $65 price target The firm says ...
BlackSky price target raised to $20 from $12 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on BlackSky (BKSY) to $20 from $12 and keeps a Buy rating on the shares. The firm says that as ...
FY2029 Earnings Forecast for ATOS Issued By HC Wainwright
Equities researchers at HC Wainwright issued their FY2029 EPS estimates for Atossa Therapeutics in a research note issued to investors on Thursday, January 30th. HC Wainwright analyst E. Bodnar ...